We are live on
!
Find out more
CCP
Clough Capital Partners Portfolio holdings
AUM
$1.04B
1-Year Est. Return
49.7%
This Fund
S&P 500
This Quarter
Est. Return
+9.21%
1 Year Est. Return
+49.7%
3 Year Est. Return
+155.82%
5 Year Est. Return
+205.73%
10 Year Est. Return
+1,385%
AUM
$1.87B
AUM Growth
-$253M
(-12%)
Cap. Flow
-$342M
Cap. Flow
% of AUM
-18.27%
Top 10 Holdings %
Top 10 Hldgs %
22.19%
Holding
263
New
54
Increased
44
Reduced
71
Closed
80
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charter Communications
CHTR
|
+$35.8M |
| 2 |
Broadcom
AVGO
|
+$30.3M |
| 3 |
Devon Energy
DVN
|
+$26.9M |
| 4 |
Amazon
AMZN
|
+$26.8M |
| 5 |
MRO
Marathon Oil Corporation
MRO
|
+$23.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$53M |
| 2 |
American International
AIG
|
+$44.1M |
| 3 |
LVNTA
Liberty Interactive Corporation Series A Liberty Ventures
LVNTA
|
+$43.5M |
| 4 |
Citigroup
C
|
+$40.4M |
| 5 |
Bank of America
BAC
|
+$38.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 18.09% |
| 2 | Communication Services | 15.79% |
| 3 | Consumer Discretionary | 12.56% |
| 4 | Technology | 11.73% |
| 5 | Healthcare | 9.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Gilead Sciences
GILD
$162B
| $5.64M | 0.3% |
+67,600
| New | +$6M |
|
102
Wave Life Sciences
WVE
$1.09B
| $5.44M | 0.29% |
262,950
-110,200
| -30% | -$1.72M |
|
|
OTIC
103
DELISTED
Otonomy, Inc.
OTIC
| $5.44M | 0.29% |
342,303
+25,800
| +8% | +$385K |
|
104
Commault Systems
CVLT
$4.88B
| $4.83M | 0.26% |
111,900
+97,765
| +692% | +$4.31M |
|
105
TotalEnergies
TTE
$195B
| $4.73M | 0.25% |
+98,289
| New | +$4.71M |
|
|
DERM
106
DELISTED
Dermira, Inc.
DERM
| $4.65M | 0.25% |
158,984
+92,600
| +139% | +$2.56M |
|
107
Fabrinet
FN
$15.6B
| $4.58M | 0.25% |
+123,400
| New | +$4.22M |
|
|
BHI
108
DELISTED
Baker Hughes
BHI
| $4.56M | 0.24% |
+101,100
| New | +$4.58M |
|
|
CLLS
109
Cellectis
CLLS
$277M
| $4.56M | 0.24% |
171,550
+10,600
| +7% | +$311K |
|
110
Boston Scientific
BSX
$69.5B
| $4.31M | 0.23% |
184,450
+8,500
| +5% | +$184K |
|
|
CHCT
111
Community Healthcare Trust
CHCT
$523M
| $4.23M | 0.23% |
+200,000
| New | +$3.79M |
|
|
LGF
112
DELISTED
Lions Gate Entertainment
LGF
| $4.22M | 0.23% |
+208,600
| New | +$4.38M |
|
113
Antero Resources
AR
$11.1B
| $3.99M | 0.21% |
+153,600
| New | +$4.19M |
|
114
Prestige Consumer Healthcare
PBH
$2.38B
| $3.92M | 0.21% |
70,700
-61,800
| -47% | -$3.4M |
|
115
Jazz Pharmaceuticals
JAZZ
$15.9B
| $3.61M | 0.19% |
25,537
-17,794
| -41% | -$2.62M |
|
|
LKFT
116
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.78B
| $3.6M | 0.19% |
64,970
+11,000
| +20% | +$553K |
|
|
DVAX
117
DELISTED
Dynavax Technologies
DVAX
| $3.56M | 0.19% |
243,884
-159,599
| -40% | -$2.73M |
|
118
TherapeuticsMD
TXMD
$23.5M
| $3.44M | 0.18% |
8,090
-228
| -3% | -$94K |
|
119
Medtronic
MDT
$109B
| $3.37M | 0.18% |
38,800
-5,500
| -12% | -$445K |
|
120
Alibaba
BABA
$293B
| $3.18M | 0.17% |
40,000
-205,050
| -84% | -$16M |
|
121
Hercules Capital
HTGC
$3.07B
| $3.15M | 0.17% |
253,700
+153,900
| +154% | +$1.87M |
|
122
AstraZeneca
AZN
$263B
| $3.11M | 0.17% |
51,565
-44,544
| -46% | -$2.59M |
|
123
Dick's Sporting Goods
DKS
$17.5B
| $2.88M | 0.15% |
+64,000
| New | +$2.79M |
|
124
Tenaris
TS
$28.9B
| $2.88M | 0.15% |
+100,000
| New | +$2.66M |
|
125
Adams Diversified Equity Fund
ADX
$3.13B
| $2.78M | 0.15% |
219,530
| – | – |
|
Similar funds
CGA
SM
RC
OPFM
MSIIA
CA
TBA
CFFNO
Clough Capital Partners's Q2 2016 Portfolio in Review
As of Q2 2016, Clough Capital Partners held 263 positions worth $1.87B, down 12% from $2.12B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
Clough Capital Partners withdrew a net $342M in Q2 2016, closing 80 positions and reducing 71 holdings. Its most notable exit was State Street Energy Select Sector SPDR ETF, an estimated $53M position sold in full.
By sector, the portfolio is most concentrated in Energy at 18% of assets, up from 7.9% a quarter earlier, followed by Communication Services and Consumer Discretionary.
Against the trend, Clough Capital Partners opened a new position in Charter Communications worth $38.1M.
- Clough Capital Partners's largest Q2 2016 buy was Charter Communications: 166,744 shares worth $38.1M.
- Clough Capital Partners added most to Broadcom in Q2 2016, an estimated $30.3M increase.
- Clough Capital Partners's biggest Q2 2016 reduction was Liberty Interactive Corporation Series A Liberty Ventures, cutting an estimated $43.5M.
- Clough Capital Partners fully exited State Street Energy Select Sector SPDR ETF in Q2 2016, selling an estimated $53M.
- Clough Capital Partners's ten largest holdings make up 22% of its $1.87B portfolio in Q2 2016.
- Clough Capital Partners opened 54 new positions and closed 80 in Q2 2016.
- Clough Capital Partners's portfolio value fell 12% quarter-over-quarter to $1.87B.
Based on Clough Capital Partners's 13F filing for Q2 2016, filed 15 Aug 2016.